Center Care (Meritain) policies
Search Center Care (Meritain)'s public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.
9 policies name J9324, those listing the fewest codes first. A policy that names a code may also list it as excluded.
| Policy | Details | Codes | Source |
|---|---|---|---|
| 0995-Amivantamab-vmjw (Rybrevant) and Amivantamab and Hyaluronidase-lpuj (Rybrevant Faspro) | 0995 · Commercial | 15 | Original policy ↗ |
| Vitamin B-12 Therapy | 0536 · Commercial | 19 | Original policy ↗ |
| 0993-Dostarlimab-gxly (Jemperli) | 0993 · Commercial | 31 | Original policy ↗ |
| 0685-Bevacizumab for Non-Ocular Indications | 0685 · Commercial | 33 | Original policy ↗ |
| Pemetrexed Products | 0687 · Commercial | 35 | Original policy ↗ |
| 0890-Pembrolizumab Products (Keytruda and Keytruda Qlex) | 0890 · Commercial | 82 | Original policy ↗ |
| Antiemetic Therapy | 0724 · Commercial | 152 | Original policy ↗ |
| Participating provider precertification list for Aetna® | 1013000-01-35 · Effective Nov 1, 2025 · Commercial | 1,389 | Original policy ↗ |
| Participating provider precertification list for Aetna® | Effective Jan 1, 2026 · Commercial | 1,440 | Original policy ↗ |